JPH10508839A - 神経保護薬としてのグリア誘導神経栄養因子 - Google Patents
神経保護薬としてのグリア誘導神経栄養因子Info
- Publication number
- JPH10508839A JPH10508839A JP8515884A JP51588496A JPH10508839A JP H10508839 A JPH10508839 A JP H10508839A JP 8515884 A JP8515884 A JP 8515884A JP 51588496 A JP51588496 A JP 51588496A JP H10508839 A JPH10508839 A JP H10508839A
- Authority
- JP
- Japan
- Prior art keywords
- gdnf
- rhgdnf
- seizures
- kainate
- neurotrophic factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 発作活性に関連した神経変性疾患を抑制することを必要とする患者に対し て、前記神経変性疾患を抑制するために有効な量のグリア誘導神経栄養因子(G DNF)を投与することを含む、前記神経変性疾患を抑制するための方法。 2. 前記神経変性疾患がてんかんである請求項1に記載の方法。 3. 前記GDNFを組換えDNA法で生産する請求項1に記載の方法。 4. 前記発作が有害量のカイニン酸によって引き起こされる請求項1に記載の 方法。 5. 前記GDNFを調剤上許容可能な担体と共に投与する請求項1に記載の方 法。 6. 前記GDNFを頭蓋内投与する請求項1に記載の方法。 7. 発作を抑制するための治療有効量のGDNFと調剤上許容可能な担体とを 含む調剤組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34082194A | 1994-11-15 | 1994-11-15 | |
US08/340,821 | 1994-11-15 | ||
PCT/IB1995/001004 WO1996014861A1 (en) | 1994-11-15 | 1995-11-13 | Glial derived neurotrophic factor as a neuroprotective agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10508839A true JPH10508839A (ja) | 1998-09-02 |
Family
ID=23335068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8515884A Ceased JPH10508839A (ja) | 1994-11-15 | 1995-11-13 | 神経保護薬としてのグリア誘導神経栄養因子 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5733875A (ja) |
EP (1) | EP0792160B1 (ja) |
JP (1) | JPH10508839A (ja) |
AT (1) | ATE205088T1 (ja) |
AU (1) | AU691349B2 (ja) |
CA (1) | CA2204911C (ja) |
DE (1) | DE69522578T2 (ja) |
DK (1) | DK0792160T3 (ja) |
ES (1) | ES2159647T3 (ja) |
IL (1) | IL115966A (ja) |
PT (1) | PT792160E (ja) |
WO (1) | WO1996014861A1 (ja) |
ZA (1) | ZA959714B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014224140A (ja) * | 2006-04-25 | 2014-12-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Cns障害の処置のための成長因子の投与 |
US11766418B2 (en) | 2016-07-22 | 2023-09-26 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184200B1 (en) * | 1995-09-28 | 2001-02-06 | Amgen Inc. | Truncated glial cell line-derived neurotrophic factor |
US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
US5641749A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
WO1997019693A1 (en) * | 1995-11-29 | 1997-06-05 | Amgen Inc. | Method for treating sensory neuropathy using glial cell line-derived neurotrophic factor (gdnf) protein product |
US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
BR9713055A (pt) | 1996-11-15 | 2000-04-04 | Genentech Inc | Processo para isolar uma neurotrofina humana recombinante, composição de neurotrofina e processo para purificar uma neurotrofina |
US6277820B1 (en) | 1998-04-09 | 2001-08-21 | Genentech, Inc. | Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells |
PT1223966E (pt) * | 1999-10-29 | 2003-09-30 | Biopharm Ges Biotechn Entwickl | Utilizacao do gdnf para tratamento de defeitos na cornea |
US20040197900A1 (en) * | 2003-04-04 | 2004-10-07 | Arnon Rosenthal | Foggy |
JP2009535360A (ja) * | 2006-04-26 | 2009-10-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 高分子量神経治療薬の対流増加送達のための組成物および方法 |
US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
WO2014152511A1 (en) | 2013-03-15 | 2014-09-25 | The Jackson Laboratory | Methods for promoting wound healing and hair growth |
AU2017357931A1 (en) | 2016-11-10 | 2019-06-20 | Keros Therapeutics, Inc. | GDNF fusion polypeptides and methods of use thereof |
EP3973979A1 (en) * | 2020-09-25 | 2022-03-30 | The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth | A tight junction (zonulae occludentes) protein for use in treating or preventing epilepsy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU220795B1 (hu) * | 1991-09-20 | 2002-05-28 | Amgen Inc. | Gliasejtvonal-eredetű neurotróf faktorfehérjék, továbbá berendezések és gyógyászati készítmények idegsejtkárosodás megelőzésére és kezelésére |
FR2717824B1 (fr) * | 1994-03-25 | 1996-04-26 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
-
1995
- 1995-05-22 US US08/446,383 patent/US5733875A/en not_active Expired - Lifetime
- 1995-11-12 IL IL11596695A patent/IL115966A/xx not_active IP Right Cessation
- 1995-11-13 DK DK95935548T patent/DK0792160T3/da active
- 1995-11-13 JP JP8515884A patent/JPH10508839A/ja not_active Ceased
- 1995-11-13 WO PCT/IB1995/001004 patent/WO1996014861A1/en active IP Right Grant
- 1995-11-13 ES ES95935548T patent/ES2159647T3/es not_active Expired - Lifetime
- 1995-11-13 AT AT95935548T patent/ATE205088T1/de not_active IP Right Cessation
- 1995-11-13 AU AU37528/95A patent/AU691349B2/en not_active Expired
- 1995-11-13 PT PT95935548T patent/PT792160E/pt unknown
- 1995-11-13 EP EP95935548A patent/EP0792160B1/en not_active Expired - Lifetime
- 1995-11-13 DE DE69522578T patent/DE69522578T2/de not_active Expired - Fee Related
- 1995-11-13 CA CA002204911A patent/CA2204911C/en not_active Expired - Fee Related
- 1995-11-15 ZA ZA9509714A patent/ZA959714B/xx unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014224140A (ja) * | 2006-04-25 | 2014-12-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Cns障害の処置のための成長因子の投与 |
US9724387B2 (en) | 2006-04-25 | 2017-08-08 | The Regents Of The University Of California | Administration of growth factors for the treatment of CNS disorders |
US11766418B2 (en) | 2016-07-22 | 2023-09-26 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Also Published As
Publication number | Publication date |
---|---|
AU691349B2 (en) | 1998-05-14 |
EP0792160B1 (en) | 2001-09-05 |
CA2204911C (en) | 2002-07-23 |
IL115966A (en) | 1999-11-30 |
WO1996014861A1 (en) | 1996-05-23 |
ATE205088T1 (de) | 2001-09-15 |
DE69522578D1 (de) | 2001-10-11 |
US5733875A (en) | 1998-03-31 |
ES2159647T3 (es) | 2001-10-16 |
PT792160E (pt) | 2002-02-28 |
AU3752895A (en) | 1996-06-06 |
DE69522578T2 (de) | 2002-07-11 |
IL115966A0 (en) | 1996-01-31 |
CA2204911A1 (en) | 1996-05-23 |
DK0792160T3 (da) | 2001-11-19 |
EP0792160A1 (en) | 1997-09-03 |
ZA959714B (en) | 1997-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10508839A (ja) | 神経保護薬としてのグリア誘導神経栄養因子 | |
JP2000507939A (ja) | 中枢神経系の虚血または外傷後のポリペプチド成長因子の投与 | |
TWI532480B (zh) | 以斑馬魚模組進行藥物篩選之方法及篩選所得藥物 | |
KR20180073683A (ko) | Rxr 아고니스트와 갑상선 호르몬의 조합을 사용한 신경계 질환의 치료 | |
Bentzer et al. | Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume | |
JP2020505365A (ja) | 治療用および神経保護用ペプチド | |
KR102015197B1 (ko) | 대상체에서의 혈관신생을 유도하기 위한 10000Da 미만의 평균 분자량을 가지는 황산덱스트란의 용도 | |
EP2444078A1 (en) | Use of amides of mono and dicarboxylic acids in the treatment of renal diseases | |
US20130012443A1 (en) | Methods of treatment of central nervous system hemorrhage using protoporphyrin ix-fe compounds | |
US20210059969A1 (en) | Alpha-aminoadipate for treatment of vision loss and restoring sight | |
KR100698449B1 (ko) | 안구 혈관신생 질환 치료용 스타우로스포린 유도체의 용도 | |
JP2015038092A (ja) | 線維性障害を処置する方法 | |
JP2002526411A (ja) | 網膜病理を治療するためのジルチアゼムの使用 | |
US20200061092A1 (en) | Methods and compositions for treating disorders associated with muscle weakness | |
US20110124706A1 (en) | SOCS3 Inhibition Promotes CNS Neuron Regeneration | |
JP2005505548A (ja) | 神経細胞変性の病気の治療のためのβ−アドレナリン受容体拮抗薬を使用する方法 | |
US20110130336A1 (en) | Method of treating ischemic injury using apoaequorin | |
JP2003534385A (ja) | 被験者の神経に有益な効果をもたらす方法および組成物 | |
US10780070B2 (en) | Alpha-aminoadipate for treatment of vision loss and restoring sight | |
EP1948217B1 (en) | Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease | |
JP2000507553A (ja) | TNF―αによる嚢胞性疾患の治療 | |
Bridges et al. | Vitamin A and interstitial retinol-binding protein in an eye with recessive retinitis pigmentosa. | |
US11351229B2 (en) | Combination therapies for treating infantile spasms and other treatment resistant epilepsies | |
Yang et al. | Retinal protection by sustained nanoparticle delivery of oncostatin M and ciliary neurotrophic factor into rodent models of retinal degeneration. Transl Vis Sci Technol. 2021; 10 (9): 6 | |
EP1161256A1 (en) | Use of nerve growth factor for therapy of intraocular tissue pathologies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060613 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060906 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061023 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070205 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070306 |